Carl L. Gordon, Ph.D., CFA

Bio

Carl is a Managing Partner and leads OrbiMed’s private equity team. Carl joined OrbiMed’s predecessor firm in 1995 and was a founding General Partner of OrbiMed in 1998. He did his undergraduate work at Harvard (A.B., Chemistry & Physics, 1987), worked at the biotechnology company Imclone Systems (1987-1988), then attained a Ph.D. in Biology from MIT (1993), and was a Postdoctoral Fellow at the Rockefeller University (1993-1995). Carl has been fortunate to have been on the Forbes Midas list of top venture capital investors multiple times. He has founded and invested in numerous biotechnology companies and served on many public and private company boards. When considering investments, Carl looks for innovative technology and creative management teams and believes the key to success is a combination of integrity, hard work, and passion.